Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.
Press releases published on April 30, 2025
Denodo Platform 9.2 מספקת חוויית שוק נתונים אינטואיטיבית הנתמכת בידי יכולות בינה מלאכותית יוצרת (GenAI) מתקדמות
GlobeNewswire
·
April 30, 2025
פאלו אלטו, קליפורניה, April 30, 2025 (GLOBE NEWSWIRE) -- Denodo, מובילה בניהול נתונים, הכריזה על השקת Denodo Platform 9.2 המוסיפה תפקודיות אינטואיטיבית חדשה ל- Denodo Platform 9.1ששוחררה בנובמבר 2024, הבונה על השכבה הסמנטית ויכולות ניהול הנתונים הלוגיות של …
Denodo Platform 9.2, 고급 생성형 AI(GenAI) 기능으로 지원되는 직관적인 데이터 마켓플레이스 경험 제공
GlobeNewswire
·
April 30, 2025
팔로 알토, April 30, 2025 (GLOBE NEWSWIRE) -- 데이터 관리 분야를 선도하는 데노도(Denodo)가 Denodo Platform 9.2를 출시한다고 발표했다. 2024년 11월에 출시한 Denodo Platform 9.1에 데노도 플랫폼 시맨틱 레이어와 논리적 데이터 관리 기능을 기반으로 모든 기능을 갖춘 데이터 마켓플레이스, GenAI 이니셔티브 지원 확대, 데이터 제품 개발을 위한 새로운 셀프서비스 툴 제품군 등 직관적인 …
Denodo Platform 9.2 借助生成式人工智能 (GenAI) 先进功能营造直观数据市场体验
GlobeNewswire
·
April 30, 2025
帕洛阿尔托，加利福尼亚州, April 30, 2025 (GLOBE NEWSWIRE) -- 数据管理领域的领导者 Denodo 宣布推出 Denodo Platform 9.2，该版本基于 2024 年 11 月发布的 Denodo Platform 9.1 新增了多项直观功能，进一步强化 Denodo Platform 在语义层与逻辑数据管理方面的核心能力。新增功能包括：功能完善的数据市场、对于 GenAI 项目的更广泛支持，以及一整套赋能数据产品开发的全新自助工具。 …
DEBRICHEM® gewinnt IIWCG Achievement Award 2025 für Innovation in der Wundversorgung
GlobeNewswire
·
April 30, 2025
AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, das Spitzenprodukt von DEBx Medical, ist auf der 16. Abu Dhabi Wound Care Conference mit dem IIWCG Achievement Award 2025 für Innovation in der Wundversorgung ausgezeichnet worden. Medien-Snippet. …
DEBRICHEM® Wins 2025 IIWCG Achievement Award for Innovation in Wound Care
GlobeNewswire
·
April 30, 2025
AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, the flagship product of DEBx Medical has been awarded the IIWCG Achievement Award 2025 for Innovation in Wound Care at the 16th Abu Dhabi Wound Care Conference. Media Snippet. Presented during the …
DEBRICHEM® זכה בפרס ההישגיות של IIWCG לשנת 2025 עבור חדשנות בטיפול בפצעים
GlobeNewswire
·
April 30, 2025
אמסטרדם, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, מוצר הדגל של DEBx Medical, זכה בפרס ההישגיות של IIWCG לשנת 2025 עבור חדשנות בטיפול בפצעים ב-16th Abu Dhabi Wound Care Conference. קטע מדיה הכרה זו, שהוענקה במהלך טקס הפתיחה של ADNEC, מטעם הקבוצה הבין …
RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
GlobeNewswire
·
April 30, 2025
BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has …
Banque Raiffeisen Partners with nCino for Intelligent Loan Management to Drive Credit Chain Digitalization
GlobeNewswire
·
April 30, 2025
LONDON, April 30, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that Banque Raiffeisen, Luxembourg’s only cooperative bank, has chosen the nCino Platform to …
Tritium präsentiert TRI-FLEX, eine revolutionäre, extrem skalierbare Ladeplattform für Elektrofahrzeuge, auf der ACT Expo 2025
GlobeNewswire
·
April 30, 2025
ANAHEIM, Kalifornien, April 30, 2025 (GLOBE NEWSWIRE) -- Tritium, ein weltweit führender Anbieter von Gleichstrom-Schnellladegeräten für Elektrofahrzeuge (Electric Vehicles, EVs), hat heute auf der ACT Expo 2025 in Anaheim, Kalifornien, seine revolutionäre …
Tritium dévoile TRI-FLEX, une plateforme de recharge ultra-évolutive révolutionnaire pour véhicules électriques, au salon ACT Expo 2025
GlobeNewswire
·
April 30, 2025
ANAHEIM, Californie, 30 avr. 2025 (GLOBE NEWSWIRE) -- Tritium, l’un des leaders mondiaux des chargeurs rapides à courant continu (CC) pour véhicules électriques (VE), a dévoilé aujourd’hui sa plateforme de recharge révolutionnaire TRI-FLEX lors du salon …
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
GlobeNewswire
·
April 30, 2025
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025 New gene expression signature for cancer patients to predict clinical response to immune checkpoint. Potential of signature to enhance …
Nicox : Résultats financiers de l’année 2024
GlobeNewswire
·
April 30, 2025
Chiffre d’affaires de Nicox SA de 7,9 millions d’euros pour l’année 2024 Produits exceptionnels de 13,7 millions d’euros suite à la cession du flux futur de redevances de VYZULTA au fond Soleus Capital Trésorerie de Nicox SA au 31 décembre 2024 de 10,5 …
Nicox Provides Full Year 2024 Financial Results
GlobeNewswire
·
April 30, 2025
Nicox SA revenue of €7.9 million for full year 2024 Exceptional income of €13.7 million following the transfer of VYZULTA’s future revenue stream to Soleus Capital Nicox SA cash of €10.5 million on 31 December 2024 and the Company estimates it is …
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
GlobeNewswire
·
April 30, 2025
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USD up by 5%[1] at a comparable growth rate (CGR), when adjusted for impact of …
La filial ZenaDrone de ZenaTech presentará sus drones a clientes potenciales del sector defensa de EE. UU. en próximas importantes conferencias
GlobeNewswire
·
April 30, 2025
VANCOUVER, Columbia Británica, April 29, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Drones como un Servicio (DaaS), …
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025
GlobeNewswire
·
April 30, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third quarter ended March 31, 2025. …